Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome
© Kambouris et al.; licensee BioMed Central Ltd. 2014
Received: 11 December 2013
Accepted: 29 May 2014
Published: 7 June 2014
A consanguineous Arab family is affected by an apparently novel autosomal recessive disorder characterized by cognitive impairment, failure-to-thrive, hypotonia and dysmorphic features including bilateral ptosis and epicanthic folds, synophrys, midface hypoplasia, downturned mouth corners, thin upper vermillion border and prominent ears, bilateral 5th finger camptodactyly, bilateral short 4th metatarsal bones, and limited knee mobility bilaterally.
The family was studied by homozygosity mapping, candidate gene mutation screening and whole Exome Next Generation Sequencing of a single affected member to identify the offending gene and mutation. The mutated gene product was studied by structural bioinformatics methods.
A damaging c.C5054G mutation affecting an evolutionary highly conserved amino acid p.S1685W was identified in the ZNF407 gene at 18q23. The Serine to Tryptophane mutation affects two of the three ZNF407 isoforms and is located in the last third of the protein, in a linker peptide adjoining two zinc-finger domains. Structural analyses of this mutation shows disruption of an H-bond that locks the relative spatial position of the two fingers, leading to a higher flexibility of the linker and thus to a decreased probability of binding to the target DNA sequence essentially eliminating the functionality of downstream domains and interfering with the expression of various genes under ZNF407 control during fetal brain development.
ZNF407 is a transcription factor with an essential role in brain development. When specific and limited in number homozygosity intervals exist that harbor the offending gene in consanguineous families, Whole Exome Sequencing of a single affected individual is an efficient approach to gene mapping and mutation identification.
KeywordsZinc finger proteins Cognitive impairment Homozygosity mapping Next generation exome sequencing In-silico protein modeling
A pregnant woman and her first cousin spouse, both of Qatari ethnic origin, presented for prenatal diagnosis because of family history of two previous male children with marked cognitive impairment and dysmorphic features, as well as, two early first trimester abortions. The cause of the miscarriages is unknown. To identify the gene and mutation responsible for the phenotype and to propose a possible underlying molecular mechanism, Homozygosity mapping, candidate gene screening, Next Generation Exome Sequencing and bioinformatics analyses of the resulting data were utilized.
Homozygosity mapping was performed for all family members utilizing the Human Mapping 370 K-Cyto12 SNP genotyping array [Illumina, USA]. For the determination of the homozygosity intervals, data were analyzed by the HomozygosityMapper software .
Sanger sequencing using Big-dye terminator v.3.1 cycle sequencing [Applied Biosystems, USA] was performed on an ABI 3730 automatic sequencer [Applied Biosystems, USA] to screen for mutations in candidate genes, perform population frequency studies for variants and determine co-segregation of variants with the disease phenotype within the family.
Whole Exome target enrichment Next Generation Sequencing was performed on ABI SOLiD4 platform [Applied Biosystems] according to manufacturer’s specifications. DNA library preparation was with TargetSeq™ Exome Enrichment system [Applied Biosystems] as multiplex fragments libraries utilizing both the SOLiD® Fragment Library Construction Kits and SOLiD® Fragment Library Barcoding Kit Module 1–16 for the SOLiD® 4 System. Bead preparation and enriching was done on an EZ Bead Emulsifier, Amplifier and Enricher utilizing E80 scale. Sequencing modality was with multiplex fragment paired-end.
Bioinformatic analyses of whole Exome NGS data was as follows: Raw data files (in a proprietary XSQ file format) were analyzed with the LifeTechnologies LifeScope v2.5.4 software running on a dedicated cluster to align the reads produced by the SoLID to a hg19 whole genome reference sequence, sourced from the University of California, Santa Cruz Genome Informatics Group (UCSC). The aligned BAM files were validated, duplicate sequences were identified and removed and incorrectly identified Mate-Pairs were corrected using the Picard v1.87 software. The Genome Analysis Tool Kit (GATK) v3.0.0 was applied to the ‘corrected’ output files to recalibrate the base quality scores, using machine learning to model any systematic errors in the data; carry out localized realignments around possible insertion/deletion sequences to ensure mapping accuracy; identify viable variants from the sequence reads; and recalibrate the variants to ensure accuracy of the variant calling, in a variant-type specific manner. Once a suitable list of variants was produced in this manner, the list was filtered using in-house scripts to confirm variant zygosity and identify those variants that conform to the inheritance model. These variants were annotated using an in-house script in conjunction with Annovar to produce an annotated list of variants with the most recent information available on a number of reference websites.
As the three-dimensional [3-D] structure of the ZNF407 protein is not available in the Protein Data Bank (PDB), sequence homology methods were utilized to construct 3-D models of the wild type and mutant zinc finger domains 18 and 19 of ZNF407. BLAST-searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) were performed within the PDB for crystal structures of homologous proteins. Once these were identified, the CLUSTALW software (http://www.ebi.ac.uk) was utilized to insure correct sequence alignments between domains 18 and 19 of ZNF407 and the retrieved zing finger structures found in the PDB. Focus was on complexes with double-stranded DNA only so as to have the proper bioactive conformation of the tandem finger. A high sequence homology with the Aart protein in complex with dsDNA (PDB code 2I13) was identified. The 3-D model of ZNF407 was then generated with the Modeller software (version 9v8)  based on the crystal structure of Aart in complex with DNA as a template (PDB code 2I13). A cycle of energy minimizations was then performed to obtain a stable conformation of the 3-D model. The quality of the model generated was finally assessed with DOPE score  and the Ramachandran plot of the best model was calculated by ProCheck  to discriminate unfavorable amino-acids backbone conformations. Three-Dimensional ribbon representations of the models were obtained with the molecular graphics program PyMOL (http://www.pymol.org). To generate the 3-D model of the mutant, Serine 1685 was replaced for a Tryptophan residue in the second finger of the 18–19 tandem finger domain and submitted to the same protocol as that used for the wild type complex. Thereafter both models were compared for an insight into the structural and thermodynamic stability effects of the mutation. To generate the 3-D model of the mutant, Serine 1685 was replaced for a Tryptophan residue in the second finger of the 18–19 tandem finger domain and submitted to the same protocol as that of the wild type complex. Thereafter, both models were compared for an insight into the structural and thermodynamic stability effects of the mutation.
The study was conducted in accordance with the provisions of the Declaration of Helsinki and an informed consent was obtained by the guardian of the affected participating family member.
Individual II:2 is an 11-year-old boy who was born at full term after an uneventful pregnancy, labor and delivery. Although the birth growth parameters are not recorded, the parents recall that all measurements were within normal limits, including the head circumference. Currently, his height is 124 cm (below the 3rd%ile) and his weight is 27 kg (at the 3rd%ile) and is reported to have a normal head circumference. His development has been delayed; he sat without support at 3 years and walked independently, with an awkward gait and bent knees, between the age of 4 and 5 years. He started to talk with very limited speech at the age of 8 years and is not toilet trained till now. Evaluation by Leiter-R [Leiter International Performance Scale] indicated severe cognitive and developmental disability with a Brief IQ of 36. The physical examination showed bilateral ptosis and epicanthic folds, synophrys, strabismus, midface hypoplasia, downturned corners of the mouth, thin upper vermillion border and prominent ears with marked folding and absent lobules. He had bilateral short fourth metatarsal bones with overriding toes, bilateral proximal insertion of the thumbs and persistent fetal pads on fingers and toes. He is hypotonic with exaggerated deep tendon reflexes. The skeletal survey showed normal hips and mild kyphosis without scoliosis. Conventional karyotyping, Array CGH, Echocardiogram and abdominal ultrasound were all reported as normal. An MRI of the brain is normal, without any evidence of structural abnormalities. Hearing test (auditory evoked potential) has been reported to be normal.
DNA from individual II:5 (Figure 2), a fetus at the time, was obtained through amniocentesis and was genotyped genome-wide identical to all other family members as well as for the c.C5054G/p.S1685W mutation. The analyses indicated that II:5 is a carrier for the c.C5054G/p.S1685W mutation (heterozygous) and the genome-wide genotyping confirms heterozygosity for the critical interval on chromosome 18 containing ZNF407. At birth it was re-confirmed that individual II:5 was not affected.
Homozygosity mapping, screening of positional candidate genes, whole Exome Next Generation Sequencing and data mining were utilized in the effort to identify the disease causing gene and mutation for this apparently novel rare autosomal recessive disease. Out of the five potentially damaging variants identified within the homozygosity intervals, the IGDCC4: c.G727A/p.D243N [rs35223184]; and C15orf39: g.G46293956A/p.R1029K [rs149175372] were immediately excluded since they represent known common polymorphisms with >1% population frequency [1000 Genomes and NCBI dbSNP Build 135].
The third identified variant, TLN2 [c.G6716A/p.R2239H], affects a non-conserved amino acid. The “alternate” amino-acid Histidine is found as the “normal” amino-acid at that position in numerous non-human species. A gene trap mouse model with disrupted Taln2, as well as Taln2 knockout mice are viable and fertile but may display a mild dystrophic phenotype in skeletal and cardiac muscles [5–7] without any neurological findings as in the family under investigation. These render this variant as extremely unlikely pathogenic in relation to the clinical phenotype of the patients.
The fourth identified variant c.G1487T/p.G496V affects a non-conserved amino acid in a known Promyelocytic Leukemia tumor suppressor [PML] gene in Acute Promyelocytic Leukemia (APL). PML mutations have been detected in APL as well as in other hematopoietic malignancies. Functional loss of PML does not relate at all to the phenotype of the family , and again this variant is extremely unlikely to be pathogenic in relation to the phenotype under investigation.
The fifth variant, a c.C5054G/p.S1685W at the zinc finger transcription factor gene (ZNF407), was found to affect an evolutionarily highly conserved amino acid. It has damaging effects according to PolyPhen and SIFT protein-modeling software [9, 10], and it co-segregates with the disease phenotype within the family. It is absent in any of the publically available variant databases [1000 Genomes and NCBI dbSNP Build 135]. Furthermore, it is absent in 400 ethnically matched control chromosomes, making it the only and most likely disease-causing gene and mutation.
Zinc finger genes are found ubiquitously, and categorized into several types based on the structure of their binding residues, and their biological roles within the cell [11, 12]. Through their ability to bind to DNA, RNA & proteins, zinc finger proteins facilitate numerous cellular functions and processes including, but not limited to, the control of hematopoiesis, regulation of gene expression, cell differentiation, and development . Their DNA-binding domain is comprised of tandem repeats of two, three or more fingers that can have different binding specificities. These tandem arrays, separated by amino acid linkers, bind through sequence-specific contact to 2–4 bases in the major groove of the DNA, spaced at 3-bp intervals [14, 15]. Optimal binding is achieved through the sequential binding and wrapping of the zinc finger domains around the DNA .
The genomic sequence of ZNF407, as reported in the Uniprot database of proteins [Uniprot consortium, 2012] is 434,710 bp long and generates a 2,248 amino acid protein product of 247,367 Da. with 22 zinc finger domains. Each of the 22 zinc finger motifs comprises from 23 to 26 amino acid residues. The 22 zinc fingers come in tandems of one (fingers 6, 7, 12 and 13), two (fingers 4–5, 8–9, 10–11), three (1–3, 14–16) and six (17–22) fingers.
ZNF407 constitutes one of the 481 ultra-conserved elements in the human genome, rendering it a functionally essential gene . It presents three isoforms produced by alternative splicing. Isoform 1 (Q9C0G0-1) is the “canonical” sequence. Isoform 2 (Q9C0G0-2) differs from the canonical sequence in amino acids 1811–1815 and amino acids 1816–2248 are missing. In isoform 3 (Q9C0G0-3), amino acids 1625–1660 are modified and residues 1661–2248 are missing. This isoform thus does not possess zinc fingers 18 to 22.
The c.C5054G [p.S1685W] mutation affects two of the three ZNF407 isoforms. It is located in the last third of the ZNF407 sequence and affects a Serine residue in the linker between zinc finger domains 18 and 19. These two zinc fingers belong to the 6-finger tandem comprising fingers 17–22. Zink fingers 18 and 19 represent amino acid residues F1656-H1680 and F1686-H1708, respectively, and are missing in isoform 3. Perturbation or modification of the linker adjoining two zinc-finger domains possibly result in the loss of DNA binding domains, thus eliminating their functionality and subsequently interfering with the expression of various genes under the zinc-finger gene control. Genes under ZNF407 control have not been as of yet identified.
The presence of Serine in position i + 4 of the ZNF407 18-19 linker is unusual and carries with it added backbone flexibility. Nevertheless, this potential flexibility is reduced by an H-bond between the hydroxyl group of S1685 at i + 4 and the carboxyl side chain of E1683 at i + 2, locking the relative spatial position of the 18 and 19 fingers. This stabilizes the linker in a β-strand-like conformation and favors the interaction with DNA by reducing the number of bioactive conformations available for binding (Figure 4b). A Serine to Tryptophan mutation in the 18–19 zinc finger linker abolishes this H-bond, leading to a more flexible linker, and thus to a decrease in the probability of zinc finger-DNA complex formation of downstream partners (Figure 4c). The expected physiological effects of this physico-chemical perturbation include interfering with the expression of genes under ZNF407 control.
DNA- and RNA-binding zinc finger proteins are transcriptional regulators with a major function controlling developmental cascades of gene expression especially during fetal brain development. Mutations in such proteins have been found to interfere with normal brain development manifested during the developmental period, thus causing severe mental retardation. They have been associated with non-syndromic X-linked mental retardation [ZNF81: OMIM 314998 ; ZNF674: OMIM 300573 , ZNF711: OMIM 300803 , autosomal recessive non-syndromic intellectual disability [ZC3H14, OMIM 613279]  and impairment in adaptive behavior that manifest during development.
ZNF407 mRNA, as well as the corresponding protein are expressed in most normal tissues with moderate nuclear and cytoplasmic positivity. These include adult, embryonic and fetal central and peripheral nervous systems (http://www.nextprot.org/db/entry/NX_Q9C0G0/expression). It is not known if there is tissue specificity for each of the three isoforms or what tissues express the two isoforms affected by the c.C5054G/p.S1685W mutation. To date, twenty polymorphisms for ZNF407 have been reported in the Domain Mapping of Disease Mutations database (DMDM) . The natural variants reported in the UniProt database entry Q9C0G0 (N69S, G512R, N972T, S1259L, A1913T) are included in DMDM. None of these, though, have been associated with known diseases. However, deletion of a critical region on 18q23 that includes the ZNF407 gene and two other zinc finger genes (ZNF516 and ZNF236), among other genes, is correlated with congenital aural atresia (CAA), which manifests a subset of phenotypes recognized by the 18q deletion (18q-) syndrome . However, the clinical picture described in this syndrome is probably due to haploinsufficiency of several genes, as we could not find any symptomatic presentation in obligate carriers. Analysis of several CAA patients led to defining the breakpoint of the deletion within ZNF407. Another identified translocation breakpoint in the third intron of the ZNF407 gene causes a reduction in the transcript of its isoform 1, resulting in non-syndromic intellectual impairment and autism . Furthermore, two de novo damaging missense mutations [c.A1436G/p.Y460C; c.C3640G/p.P1195A] in the very long linker region between zinc fingers 3 and 4, and between 11 and 12, respectively, of the ZNF407 gene were found in one intellectual impairment patient each. Both patients were heterozygous, each for their relevant mutation.
This is the first association of ZNF407 mutation to an autosomal recessive syndromic intellectual impairment/mental retardation detected using Whole Exome Sequencing of a single affected individual following the determination of specific gene mapping intervals through homozygosity mapping. This proved to be the most efficient approach to gene and mutation identification, as compared to multiple family-member Whole Exome Sequencing with the resulting comparative analyses, or to candidate gene screening by Sanger sequencing when multiple candidates exist.
Next Generation Exome and Genome sequencing have clearly demonstrated that humans harbor numerous deleterious mutations with no apparent ill effect [26, 27]. The built-in redundancy in the human genome provides alternate pathways that make possible compensation for deleterious mutations in important genes without which there would be incompatibility with life. Thus, deleterious mutations resulting from NGS data need to be supported by additional genomic or functional data whenever possible. The ZNF407 c.C5054G/p.S1685W mutation is the only mutation that lies within one of the homozygosity intervals that is certain to harbor the offending gene that could not be excluded as the disease causing mutation. It co-segregates with the disease phenotype within the family, it is not found as a polymorphic variant in publically available databases or in the ethnic population and it affects an evolutionarily highly conserved amino acid. Normal sequence variants [polymorphisms] have not been reported in ZNF407 linker regions (between zinc fingers) providing further evidence of the sequence specificity required by these regions for normal function and subsequently for the damaging effects of the mutation. Extensive protein modeling clearly indicates that the mutation interferes with the normal function of the ZNF407 protein.
Taken together, these data highlight the significance of the c.C5054G/p.S1685W mutation and the role of the ZNF407 gene in controlling the expression of downstream genes involved in pathways leading to normal fetal brain development. Once disrupted, one or more dimensions of brain development get affected. With this pausing as a pivotal step in normal brain development, it is worth understanding the underlying molecular mechanism by which this mutation eliminates or significantly alters the functionality of ZNF407, thus compromising the developmental pathway ZNF407 is involved in. The model presented proposes a rational account of such molecular mechanism.
This publication was made possible in part by NPRP grant 09-367-3-087 titled “Genetic Factors In Autosomal Recessive Disorders Among Consanguineous Qatari Families” from the Qatar National Research Fund [a member of Qatar Foundation] and in part by the Shafallah Center Foundation (Doha, Qatar).
The authors would like to thank Dr. Vasiliki Chini for the valuable help with the preparation of this manuscript and the submission logistics, and the Service de coopération et d’action culturelle of the French Embassy in Doha for constant support.
- Seelow D, Schuelke M, Hildebrandt F, Nürnberg P: HomozygosityMapper--an interactive approach to homozygosity mapping. Nucleic Acids Res. 2009, 37 (Web Server issue): W593-W599.View ArticlePubMedPubMed CentralGoogle Scholar
- Fiser A, Modeller SA: Generation and refinement of homology-based protein structure models. Methods Enzymol. 2003, 374: 461-491.View ArticlePubMedGoogle Scholar
- Shen MY, Sali A: Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006, 15 (11): 2507-2524. 10.1110/ps.062416606.View ArticlePubMedPubMed CentralGoogle Scholar
- Laskowski RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK-a program to check the stereochemical quality of protein structures. J Appl Cryst. 1993, 26: 283-291. 10.1107/S0021889892009944.View ArticleGoogle Scholar
- Senetar MA, Moncman CL, McCann RO: Talin2 is induced during striated muscle differentiation and is targeted to stable adhesion complexes in mature muscle. Cell Motil Cytoskeleton. 2007, 64 (3): 157-173. 10.1002/cm.20173.View ArticlePubMedGoogle Scholar
- Chen NT, Lo SH: The N-terminal half of talin2 is sufficient for mouse development and survival. Biochem Biophys Res Commun. 2005, 337 (2): 670-676. 10.1016/j.bbrc.2005.09.100.View ArticlePubMedGoogle Scholar
- Debrand E, Conti FJ, Bate N, Spence L, Mazzeo D, Pritchard CA, Monkley SJ, Critchely DR: Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. Biochem Biophys Res Commun. 2012, 426 (2): 190-195. 10.1016/j.bbrc.2012.08.061.View ArticlePubMedPubMed CentralGoogle Scholar
- Gurrieri C, Nafa K, Merghoub T, Bernardi R, Capodieci P, Biondi A, Douer D, Cordon-Cardo C, Gallagher R, Pandolfi PP: Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood. 2004, 103 (6): 2358-2362. 10.1182/blood-2003-07-2200.View ArticlePubMedGoogle Scholar
- Ng PC, Henikoff S: SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31 (13): 3812-3814. 10.1093/nar/gkg509.View ArticlePubMedPubMed CentralGoogle Scholar
- Ramensky V, Bork P, Sunyaev S: Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002, 30 (17): 3894-3900. 10.1093/nar/gkf493.View ArticlePubMedPubMed CentralGoogle Scholar
- Krishna SS, Majumdar I, Grishin NV: Structural classification of zinc fingers: survey and summary. Nucleic Acids Res. 2003, 31 (2): 532-550. 10.1093/nar/gkg161.View ArticlePubMedPubMed CentralGoogle Scholar
- Matthews JM, Sunde M: Zinc fingers–folds for many occasions. IUBMB Life. 2002, 54 (6): 351-355. 10.1080/15216540216035.View ArticlePubMedGoogle Scholar
- Razin SV, Borunova VV, Maksimenko OG, Kantidze OL: Cys2His2 zinc finger protein family: classification, functions, and major members. Biochem Biokhimiia. 2012, 77 (3): 217-226. 10.1134/S0006297912030017.View ArticleGoogle Scholar
- Emerson RO, Thomas JH: Adaptive evolution in zinc finger transcription factors. PLoS Genet. 2009, 5 (1): e1000325-10.1371/journal.pgen.1000325.View ArticlePubMedPubMed CentralGoogle Scholar
- Wolfe SA, Nekludova L, Pabo CO: DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct. 2000, 29: 183-212. 10.1146/annurev.biophys.29.1.183.View ArticlePubMedGoogle Scholar
- Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, Haussler D: Ultraconserved elements in the human genome. Science. 2004, 304 (5675): 1321-1325. 10.1126/science.1098119.View ArticlePubMedGoogle Scholar
- Segal DJ, Crotty JW, Bhakta MS, Barbas CF, Horton NC: Structure of Aart, a designed six-finger zinc finger peptide, bound to DNA. J Mol Biol. 2006, 363 (2): 405-421. 10.1016/j.jmb.2006.08.016.View ArticlePubMedGoogle Scholar
- Kleefstra T, Yntema HG, Oudakker AR, Banning MJG, Kalscheuer VM, Chelly J, Moraine C, Ropers HH, Fryns JP, Janssen IM, Sistermans EA, Nillesen WN, de Vries LB, Hamel BC, van Bokhoven H: Zinc finger 81 (ZNF81) mutations associated with X-linked mental retardation. J Med Genet. 2004, 41 (5): 394-399. 10.1136/jmg.2003.016972.View ArticlePubMedPubMed CentralGoogle Scholar
- Lugtenberg D, Yntema HG, Banning MJG, Oudakker AR, Firth HV, Willatt L, Raynaud M, Kleefstra T, Fryns JP, Ropers HH, Chelly J, Moraine C, Gecz J, van Reeuwijk J, Nabuurs SB, de Vries BB, Hamel BC, de Brouwer AP, van Bokhoven H: ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. Am J Hum Genet. 2006, 78 (2): 265-278. 10.1086/500306.View ArticlePubMedPubMed CentralGoogle Scholar
- Tarpey PS, Smith R, Pleasance E, Whibley A, Edkins S, Hardy C, O’Meara S, Latimer C, Dicks E, Menzies A, Stephens P, Blow M, Greenman C, Xue Y, Tyler-Smith C, Thompson D, Gray K, Andrews J, Barthorpe S, Buck G, Cole J, Dunmore R, Jones D, Maddison M, Mironenko T, Turner R, Turrell K, Varian J, West S, Widaa S: A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet. 2009, 41 (5): 535-543. 10.1038/ng.367.View ArticlePubMedPubMed CentralGoogle Scholar
- Pak C, Garshasbi M, Kahrizi K, Gross C, Apponi LH, Noto JJ, Kelly SM, Leung SW, Tzschach A, Behjati F, Abedini SS, Mohseni M, Jensen LR, Hu H, Huang B, Stahley SN, Liu G, Williams KR, Burdick S, Feng Y, Sanyal S, Bassell GJ, Ropers HH, Najmabadi H, Corbett AH, Moberg KH, Kuss AW: Mutation of the conserved polyadenosine RNA binding protein, ZC3H14/dNab2, impairs neural function in Drosophila and humans. Proc Natl Acad Sci U S A. 2011, 108 (30): 12390-12395. 10.1073/pnas.1107103108.View ArticlePubMedPubMed CentralGoogle Scholar
- Peterson TA, Adadey A, Santana-Cruz I, Sun Y, Winder A, Kann MG: DMDM: domain mapping of disease mutations. Bioinformatics. 2010, 26 (19): 2458-2459. 10.1093/bioinformatics/btq447.View ArticlePubMedPubMed CentralGoogle Scholar
- Cody JD, Hasi M, Soileau B, Heard P, Carter E, Sebold C, O’Donnell L, Perry B, Stratton RF, Hale DE: Establishing a reference group for distal 18q-: clinical description and molecular basis. Hum Genet. 2014, 133: 199-209. 10.1007/s00439-013-1364-6.View ArticlePubMedPubMed CentralGoogle Scholar
- Dostal A, Nemeckova J, Gaillyova R, Vranova V, Zezulkova D, Lejska M, Slapak I, Dostalova Z, Kuglik P: Identification of 2.3-Mb gene locus for congenital aural atresia in 18q22.3 deletion: a case report analyzed by comparative genomic hybridization. Otol Neurotol. 2006, 27 (3): 427-432. 10.1097/00129492-200604000-00022.View ArticlePubMedGoogle Scholar
- Ren CM, Liang Y, Wei F, Zhang YN, Zhong SQ, Gu H, Dong XS, Huang YY, Ke H, Son XM, Tang D, Chen Z: Balanced translocation t(3;18)(p13;q22.3) and points mutation in the ZNF407 gene detected in patients with both moderate non-syndromic intellectual disability and autism. Biochim Biophys Acta. 2013, 1832 (3): 431-438. 10.1016/j.bbadis.2012.11.009.View ArticlePubMedGoogle Scholar
- Chun S, Fay JC: Identification of deleterious mutations within three human genomes. Genome Res. 2009, 19 (9): 1553-1561. 10.1101/gr.092619.109.View ArticlePubMedPubMed CentralGoogle Scholar
- Chun S, Fay JC: Evidence for hitchhiking of deleterious mutations within the human genome. PLoS Genet. 2011, 7 (8): e1002240-10.1371/journal.pgen.1002240.View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.